PHC-12-2015-1
PHC-12-2015-1
87 projects · €4,350,000 total EU contribution (project-level) · 88 participating organizations · 21 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€4,350,000
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (12)
- Germany (11)
- Spain (11)
- Italy (11)
- SE (8)
- France (6)
- IL (6)
- DK (4)
- AT (3)
- HU (3)
- IE (2)
- Netherlands (2)
- BE (1)
- BG (1)
- EE (1)
- FI (1)
- IS (1)
- NO (1)
- PT (1)
- SI (1)
- TR (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- AETHRA TELECOMMUNICATIONS1 projects · IT
- ACONET1 projects · IT
- ADAPTIX1 projects · UK
- BIFARMA1 projects · HU
- ALAM MEDICAL1 projects · FR
- ANANDA PHARMA1 projects · DE
- ANAXSYS TECHNOLOGY LTD1 projects · UK
- ANGIOTARGET BV1 projects · NL
- AROCELL AB1 projects · SE
- ATTOMARKER LIMITED1 projects · UK
- Atturos1 projects · IE
- AVERBIS GMBH1 projects · DE
Projects
Page 3 of 9
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Improving diagnostics of respiratory diseases and boosting the COMAC MEDICAL Ltd. competitiveness and growth by validation of fractional EBT biomarker through new method of measurement and device FrEBT · 696579 | H2020 | €50,000 | €71,429 | Details |
NEBU-ONE : A revolutionary method for anatomic pathology slides staining NEBU-ONE · 718669 | H2020 | €50,000 | €71,429 | Details |
Alzheimer’s Disease Diagnosis by Spectroscopy. Accurate and Non-Invasive Medical Device for the Diagnosis of Early Stage Alzheimer's Disease. ADiRaS · 683708 | H2020 | €50,000 | €71,429 | Details |
Strategic planning for commercialisation of a multiplexed protein diagnostic (Dx) blood test for Organ-Confined Prostate cancer: OCProDx OCProDx · 711761 | H2020 | €50,000 | €71,429 | Details |
Clinical validation of Trop-2 as a serum biomarker for monitoring of disease-course in patients affected by breast and colon cancer ThruBlood · 719856 | H2020 | €50,000 | €71,429 | Details |
A BIOmarker-based assay for prognosis and monitoring in renal TRANSplantation TRANSBIO · 710095 | H2020 | €50,000 | €71,429 | Details |
Clinical research for the validation of a non-invasive medical imaging device for dermatological diagnoses DERMAE · 685041 | H2020 | €50,000 | €71,429 | Details |
A novel reliable diagnostic device to avoid unnecessary thyroid surgery ThyroTrust · 711330 | H2020 | €50,000 | €71,429 | Details |
AntibioDx: A groundbreaking in vitro diagnostic device with a billion-dollar sales potential AntibioDx · 697471 | H2020 | €50,000 | €71,429 | Details |
Prostate cancer diagnostic assay based on protein kinase activity profiling in exosomes ProCanEx · 684709 | H2020 | €50,000 | €71,429 | Details |